Ericsson and TDC to deploy 5G network across Denmark by end of 2020
By Nikita Chaurasia  Date: 2020-09-08

Ericsson and TDC to deploy 5G network across Denmark by end of 2020

Telefonaktiebolaget LM Ericsson, a Swedish multinational telecommunications giant, has reportedly teamed up with a Danish communication services provider TDC in an effort to boost 5G deployment across Denmark by the end of 2020.

As per the trusted sources, the fast deployment by Ericsoon’s professionals will allow TDC to introduce commercial 5G technologies across major parts of Denmark in September 2020.

It is to be noted that the site deployment of the 5G products and solutions was initiated in October 2019. Since then, over 3000 base station sites have been deployed across Denmark, with additional plans of implementing more than 100 sites every week, sources claimed. 

Andreas Pfisterer, CEO at TDC NET was reported saying that the company is thrilled to achieve its ambitions of introducing a 5G coverage at a national level, while offering access to fast speeds in the center of Odense, Copenhagen, Aarhus and Helsingør.

Andreas further added that it was important to launch the strong 5G infrastructure in order to handle mobile data consumption that is growing with a rate of 40% annually.

Head of Central and Northern Europe at Ericsson Jenny Lindqvist mentioned that that the telecommunications company entered a joint venture agreement with TDC in an effort to meet the demand for 5G network deployment.

Jenny added that the collaboration with TDC has resulted in implementation of the first industrial 5G network in Denmark with Grundfos, and has created new opportunities in the 5G spectrum for key industries such as healthcare, manufacturing, media and entertainment.

Incidentally, TDC’s 5G implementation on 3.5GHz spectrum band included cities like Odense, Copenhagen, Aarhus and Helsingør. Sources aware of the development also stated that the rapid 5G network deployment surpassed TDC’s target timeline by over three months.

Source credits-

https://www.ericsson.com/en/news/2020/9/tdc-denmark-goes-live-with-ericsson-5g

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...